March 11, 2008 – Medtronic Inc. will feature its newly FDA-cleared Endeavor Zotarolimus-Eluting Coronary Stent System (Endeavor) at the American College of Cardiology's 57th Annual Scientific Session, from March 29-April 1, in Chicago, IL, marking a major development in the field of interventional cardiology for the company.

Endeavor is engineered for the treatment of coronary artery disease. The stent’s design combines a stent platform with the drug zotarolimus and a biocompatible polymer.

March 11, 2008 - Sorin Group's ELA Medical received the FDA’s approval to market ISOLINE, a new defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety, in a move that strengthens the company’s position in the U.S. market.

March 11, 2008 - Abbott announced today that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm version of its XIENCE V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the safety results and deliverability of XIENCE V.

March 10, 2008 – On March 10 and 11, at Rush University Medical Center (RUSH), Chicago, IL, a mechanical circulatory support and heart transplant team will participate in the first phase of certification training for the CardioWest temporary Total Artificial Heart (TAH-t), which could designate Rush as one of the first U.S. healthcare facilities able to discharge artificial heart patients home for their recovery.

March 11, 2008 – Bayer HealthCare Pharmaceuticals Inc. unveiled plans to launch VistaTrak, a contrast media management system that provides a new management tool designed to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of Congress who urged the Centers for Medicare & Medicaid Services (CMS) to reconsider its proposed national coverage decision (NCD) that will limit patient access to cardiac computed tomography angiography (CCTA).

Fujifilm will highlight the newest CVIIS release Version 4.0 from ProSolv Cardiovascular. This release, which integrates with Fujifilm’s Synapse radiology PACS Version 3.2.1, is a Web-based application for full viewing and reporting capabilities using Web communication protocols, secured via SSL, in addition to a web URL single-click application download and installation.

Volcano Corp. offers the s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access to phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform. The two products enable rotational IVUS and FFR to operate on the same integrated Volcano s5 Imaging System as Volcano’s previous line of phased array IVUS catheters and functionality.

NovaRad’s NovaPACS Cardio Viewer offers sign-on access to images or over a Web site. Features in this module include: image calibration based on catheter size, percent stenosis, choose series, cine tools, digital subtraction (displays contrast-filled vessels without any interfering background), ejection fraction and image-sharpening algorithms.

Images from the system are stored on an Online RAID 5 Archive designed with the capacity to display multiple cardiac images simultaneously and access to patient’s entire radiological or cardiological history.

ZollĂŻ's E Series defibrillators with a 12-lead reportedly offer a variety of transmission solutions and can be tailored to a specific infrastructure and budget. ZOLL Data Relay provides connectivity from the field to the hospital via fax or email, and can wirelessly transmit to a PDA so allowing users to make an assessment at any time and place, according to the company.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now